Yu‐Ming Chuang

478 total citations
13 papers, 217 citations indexed

About

Yu‐Ming Chuang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Yu‐Ming Chuang has authored 13 papers receiving a total of 217 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Yu‐Ming Chuang's work include Epigenetics and DNA Methylation (6 papers), Histone Deacetylase Inhibitors Research (3 papers) and Immune Cell Function and Interaction (3 papers). Yu‐Ming Chuang is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Histone Deacetylase Inhibitors Research (3 papers) and Immune Cell Function and Interaction (3 papers). Yu‐Ming Chuang collaborates with scholars based in Taiwan, United States and Switzerland. Yu‐Ming Chuang's co-authors include Ping‐Chih Ho, Michael W.Y. Chan, Michael W.Y. Chan, Pearlly S. Yan, Liuyang Zhao, Yun Kit Yeoh, Jun Yu, William Ka Kei Wu, Olabisi Oluwabukola Coker and Matthew T.V. Chan and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Yu‐Ming Chuang

13 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Ming Chuang Taiwan 8 138 58 44 37 23 13 217
Karthikeyan Pethusamy India 8 160 1.2× 47 0.8× 34 0.8× 17 0.5× 26 1.1× 17 260
Wesley Huang United States 6 187 1.4× 59 1.0× 29 0.7× 25 0.7× 41 1.8× 14 274
Jiayu Zhang China 11 108 0.8× 59 1.0× 36 0.8× 51 1.4× 17 0.7× 22 271
Claire Buchta Rosean United States 5 145 1.1× 118 2.0× 24 0.5× 38 1.0× 16 0.7× 7 242
Kebo Zhong China 7 151 1.1× 48 0.8× 51 1.2× 41 1.1× 14 0.6× 17 250
Binshen Ouyang China 4 106 0.8× 27 0.5× 24 0.5× 24 0.6× 13 0.6× 9 167
Carolin Perleberg Germany 6 123 0.9× 36 0.6× 27 0.6× 32 0.9× 11 0.5× 9 231
Allison Izsak United States 4 157 1.1× 124 2.1× 24 0.5× 28 0.8× 15 0.7× 6 208
Jessica Karta Luxembourg 2 154 1.1× 80 1.4× 29 0.7× 11 0.3× 16 0.7× 3 194
Carolina Soto Chervin United States 2 187 1.4× 123 2.1× 34 0.8× 32 0.9× 34 1.5× 2 284

Countries citing papers authored by Yu‐Ming Chuang

Since Specialization
Citations

This map shows the geographic impact of Yu‐Ming Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ming Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ming Chuang more than expected).

Fields of papers citing papers by Yu‐Ming Chuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ming Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ming Chuang. The network helps show where Yu‐Ming Chuang may publish in the future.

Co-authorship network of co-authors of Yu‐Ming Chuang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ming Chuang. A scholar is included among the top collaborators of Yu‐Ming Chuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ming Chuang. Yu‐Ming Chuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tsai, Chung‐Ying, Cheng-Lung Hsu, Tzong-Shyuan Tai, et al.. (2025). Asparagine deprivation enhances T cell antitumour response in patients via ROS-mediated metabolic and signal adaptations. Nature Metabolism. 7(5). 918–927. 9 indexed citations
2.
Bevilacqua, Alessio, Fabien Franco, Kung‐Chi Kao, et al.. (2024). PPARβ/δ-orchestrated metabolic reprogramming supports the formation and maintenance of memory CD8 + T cells. Science Immunology. 9(98). eadn2717–eadn2717. 11 indexed citations
3.
Chuang, Yu‐Ming, Sheue‐Fen Tzeng, Ping‐Chih Ho, & Chin‐Hsien Tsai. (2024). Immunosurveillance encounters cancer metabolism. EMBO Reports. 25(2). 471–488. 17 indexed citations
4.
Franco, Fabien, Alessio Bevilacqua, Kung‐Chi Kao, et al.. (2023). Regulatory circuits of mitophagy restrict distinct modes of cell death during memory CD8 + T cell formation. Science Immunology. 8(87). eadf7579–eadf7579. 22 indexed citations
5.
Kuo, Fu‐Chen, Yu‐Ming Chuang, Wenlong Huang, et al.. (2023). Prenatal DEHP exposure predicts neurological disorders via transgenerational epigenetics. Scientific Reports. 13(1). 7399–7399. 8 indexed citations
6.
Chuang, Yu‐Ming, et al.. (2022). Interplay between ceRNA and Epigenetic Control of microRNA: Modelling Approaches with Application to the Role of Estrogen in Ovarian Cancer. International Journal of Molecular Sciences. 23(4). 2277–2277. 5 indexed citations
7.
Yang, Shuyi, Chi‐Wen Tu, Wenlong Huang, et al.. (2022). PCDHB15 as a potential tumor suppressor and epigenetic biomarker for breast cancer. Oncology Letters. 23(4). 117–117. 6 indexed citations
8.
Yeh, Kun‐Tu, Yu‐Ming Chuang, Yu‐Ting Lee, et al.. (2021). Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers. PLoS ONE. 16(4). e0250499–e0250499. 4 indexed citations
9.
Jou, Yeong‐Chin, Hon‐Yi Lin, Yu‐Ming Chuang, et al.. (2021). Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma. Cancer Cell International. 21(1). 226–226. 5 indexed citations
10.
Wei, Kuo‐Liang, Jian‐Liang Chou, Jinglan Liu, et al.. (2021). Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling, Leads to Tumor Progression Through Overexpression of YWHAZ in Gastric Cancer. Frontiers in Oncology. 11. 575667–575667. 9 indexed citations
11.
Lee, Yu‐Ting, Yu‐Ming Chuang, & Michael W.Y. Chan. (2020). Combinatorial Epigenetic and Immunotherapy in Breast Cancer Management: A Literature Review. Epigenomes. 4(4). 27–27. 7 indexed citations
12.
Wu, William Ka Kei, Sunny H. Wong, Dabin Liu, et al.. (2020). Bacteria pathogens drive host colonic epithelial cell promoter hypermethylation of tumor suppressor genes in colorectal cancer. Microbiome. 8(1). 108–108. 100 indexed citations
13.
Chuang, Yu‐Ming, Ru‐Inn Lin, Hon‐Yi Lin, et al.. (2019). c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma. Cancers. 11(10). 1457–1457. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026